文献速递糖尿病肥胖与代谢综合征

新诊断2型糖尿病患者深层皮下脂肪组织扩张且线粒体效率受损

Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该研究纳入新诊断男性2型糖尿病患者和腹壁皮下脂肪厚度、脂肪量和年龄相近的健康男性对照各14例,通过高胰岛素-正葡萄糖钳夹、间接测热法及高分辨率呼吸测定评估脂肪组织线粒体效率。结果显示患者深层皮下脂肪扩张、线粒体效率降低,且与肌肉胰岛素敏感性和代谢灵活性相关。

要点

  • 新诊断2型糖尿病患者深层皮下脂肪厚度增加且线粒体效率降低。
  • 线粒体偶联与肌肉胰岛素敏感性及代谢灵活性正相关。
  • 深层皮下脂肪扩张与肌肉胰岛素敏感性负相关、与游离脂肪酸正相关。

核心结论

  • 新诊断2型糖尿病存在线粒体功能受损、胰岛素抵抗和深层皮下脂肪扩张,可能促进全身胰岛素抵抗和底物向肝脏流入增加。

研究设计与样本

  • 研究纳入新诊断男性2型糖尿病患者和腹壁皮下脂肪厚度、脂肪量及年龄相近的健康男性对照各14例。
  • 受试者接受高胰岛素-正葡萄糖钳夹联合[6,6-2H2]葡萄糖和间接测热法。
  • 通过高分辨率呼吸测定评估浅层和深层皮下脂肪组织活检的线粒体效率。
  • 采用质子磁共振波谱和成像评估肝细胞脂质和脂肪量。

主要发现

  • 2型糖尿病患者(已知糖尿病病程2.5[0.1;5.0]年)肌肉胰岛素敏感性、代谢灵活性和脂肪组织胰岛素敏感性分别降低43%、44%和63%(P<0.01,P<0.05)。
  • 2型糖尿病患者肝细胞脂质和深层皮下脂肪厚度分别增加73%和31%(P<0.05,P<0.001),肝脏胰岛素敏感性与对照相似。
  • 2型糖尿病患者浅层和深层皮下脂肪线粒体效率降低约22%(P<0.001),浅层较深层低约8%(P<0.05)。
  • 两个脂肪库中线粒体偶联与肌肉胰岛素敏感性和代谢灵活性正相关(r≥0.40;P<0.05),质子漏与空腹游离脂肪酸正相关(r≥0.51;P<0.01)。
  • 深层皮下脂肪厚度与两个脂肪库线粒体偶联负相关(r≤-0.50;P<0.01),与钳夹期间游离脂肪酸正相关(r=0.63;P<0.001)。

临床怎么用

  • 新诊断2型糖尿病患者需关注深层皮下脂肪扩张及线粒体功能受损,其与胰岛素抵抗相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT/OBJECTIVE: Impaired adipose tissue (AT) function might induce recent-onset type 2 diabetes (T2D). Understanding AT energy metabolism could yield novel targets for the treatment of T2D. DESIGN/PATIENTS: Male patients with recently-diagnosed T2D and healthy male controls (CON) of similar abdominal subcutaneous AT (SAT)-thickness, fat mass, and age (n = 14 each), underwent hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose and indirect calorimetry. We assessed mitochondrial efficiency (coupling: state 3/4o; proton leak: state 4o/u) via high-resolution respirometry in superficial (SSAT) and deep (DSAT) SAT-biopsies, hepatocellular lipids (HCL) and fat mass by proton-magnetic-resonance-spectroscopy and -imaging. RESULTS: T2D patients (known diabetes duration: 2.5 [0.1; 5.0] years) had 43%, 44%, and 63% lower muscle insulin sensitivity (IS), metabolic flexibility (P < 0.01) and AT IS (P < 0.05), 73% and 31% higher HCL (P < 0.05), and DSAT-thickness (P < 0.001), but similar hepatic IS compared with CON. Mitochondrial efficiency was ~22% lower in SSAT and DSAT of T2D patients (P < 0.001) and ~8% lower in SSAT vs DSAT (P < 0.05). In both fat depots, mitochondrial coupling correlated positively with muscle IS and metabolic flexibility (r ≥ 0.40; P < 0.05), proton leak correlated positively (r ≥ 0.51; P < 0.01) and oxidative capacity negatively (r ≤ -0.47; P < 0.05) with fasting free fatty acids (FFA). Metabolic flexibility correlated positively with SAT-oxidative capacity (r ≥ 0.48; P < 0.05) and negatively with DSAT-thickness (r = -0.48; P < 0.05). DSAT-thickness correlated negatively with mitochondrial coupling in both depots (r ≤ -0.50; P < 0.01) and muscle IS (r = -0.59; P < 0.01), positively with FFA during clamp (r = 0.63; P < 0.001) and HCL (r = 0.49; P < 0.01). CONCLUSIONS: Impaired mitochondrial function, insulin resistance, and DSAT expansion are AT abnormalities in recent-onset T2D that might promote whole-body insulin resistance and increased substrate flux to the liver.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bódis K, Jelenik T, Lundbom J, et al. Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 31838512. doi:10.1210/clinem/dgz267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。